Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT ASSETS (Tables)

12 Months Ended

Dec. 31, 2023

Inventories consisted of the following (in thousand):


	As of December 31
	2023			2022
Raw materials and components	$	1,329		$	1,393
Work-in-process		186			513
Finished goods		5,163			5,428
Inventory reserve		(4,967	)		(4,955	)
Total inventories, net	$	1,711		$	2,379

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of December 31
	2023		2022
Prepaid insurance	$	595	$	598
Prepaid expenses		536		467
Other current assets		596		449
Total prepaid expenses and other current assets	$	1,727	$	1,514

Property and equipment consisted of the following (in thousands):


	As of December 31
	2023			2022
Equipment	$	383		$	367
Leasehold improvements		39			39
Furniture and fixtures		99			99
Total property and equipment		521			505
Less: accumulated depreciation		(462	)		(430	)
Total property and equipment, net	$	59		$	75